Related Experiment Video
Updated: Jul 21, 2025

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
Published on: June 23, 2023
Cognitive Alterations in Addictive Disorders: A Translational Approach
Ani Gasparyan1,2,3, Daniel Maldonado Sanchez4, Francisco Navarrete1,2,3
1Instituto de Neurociencias, Universidad Miguel Hernández-CSIC, Avda de Ramón y Cajal s/n, 03550 San Juan de Alicante, Spain.
Abstract:
The cognitive decline in people with substance use disorders is well known and can be found during both the dependence and drug abstinence phases. At the clinical level, cognitive decline impairs the response to addiction treatment and increases dropout rates. It can be irreversible, even after the end of drug abuse consumption. Improving our understanding of the molecular and cellular alterations associated with cognitive decline could be essential to developing specific therapeutic strategies for its treatment. Developing animal models to simulate drug abuse-induced learning and memory alterations is critical to continue exploring this clinical situation. The main aim of this review is to summarize the most recent evidence on cognitive impairment and the associated biological markers in patients addicted to some of the most consumed drugs of abuse and in animal models simulating this clinical situation. The available information suggests the need to develop more studies to further explore the molecular alterations associated with cognitive impairment, with the ultimate goal of developing new potential therapeutic strategies.
Insights
Substance use disorders cause cognitive decline, impacting addiction treatment outcomes. Further research into molecular changes is crucial for developing targeted therapies for memory and learning impairments.
Area of Science:
- Neuroscience
- Addiction Research
- Pharmacology
Background:
- Cognitive decline is a significant issue in substance use disorders (SUDs), persisting through dependence and abstinence.
- This decline negatively affects treatment efficacy and increases patient dropout rates, with potential for irreversibility.
Purpose of the Study:
- To review current evidence on cognitive impairment in individuals with SUDs and relevant animal models.
- To identify associated biological markers and explore molecular alterations underlying cognitive deficits.
Main Methods:
- Systematic review of recent literature on cognitive function in SUD patients.
- Analysis of studies using animal models to investigate drug abuse-induced learning and memory deficits.
- Examination of biological markers linked to cognitive impairment in SUDs.
Main Results:
- Cognitive impairment is prevalent in various substance use disorders.
- Animal models effectively simulate learning and memory alterations seen in human SUDs.
- Biological markers associated with cognitive decline are being identified, though further research is needed.
Conclusions:
- Understanding molecular and cellular alterations is key to developing effective therapeutic strategies for SUD-related cognitive decline.
- Continued investigation into biological markers and molecular pathways is essential for novel treatment development.
- Developing robust animal models is critical for advancing research in this field.
Related Concept Videos
Drug Abuse and Addiction: Pharmacological Phenomena
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
CNS Depressants: Alcohol and Nicotine
Long-term Depression
Calcium Ion Concentration Mechanism
If over...
Drug Dependence

